rnarco

Viropharma: Failed Bet on Orphan Drug

Another Monday morning quarterback. Another useless analysis post fact.

R&D Costs of the Pfizer / Wyeth Deal

Your comments can be applied to any acquisition or merger in the marketplace, so why single out just Pfizer/Wyeth. More importantly what do you suggest as an alternative? Unless you are talking major regulation changes that eliminate the delays in getting acquisitions/merger approved (which will never happen), then this is the process that we all have to live with. Do not blame someone for something they have no control over, that is the delay that ensues after a deal like this is announced and the uncertainty surrounding it.

Online Advertising: ING Direct vs E*Trade

Honestly, who cares?